We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
cbdMD Inc | AMEX:YCBD | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.88 | 0.93 | 0.826 | 0.90 | 458,498 | 01:00:00 |
cbdMD, INC.
|
(Exact name of registrant as specified in its charter)
|
North Carolina
|
001-38299
|
47-3414576
|
(State or other jurisdiction of incorporation or
organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
_______________________________________
|
(Former name or former address, if changed since last
report)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
common
|
YCBD
|
NYSE
American
|
8%
Series A Cumulative Convertible Preferred Stock
|
YCBDpA
|
NYSE
American
|
Emerging
growth company ☑
|
|
Proposal 1:
|
The
following directors were elected at the 2021 annual meeting of
shareholders to hold office until the 2022 annual meeting of
shareholders or their earlier resignation, removal or
death:
|
Directors
|
“For”
|
“Against”
|
Broker
Non-Votes
|
Martin A.
Sumichrast
|
26,950,323
|
101,529
|
7,751,239
|
R. Scott
Coffman
|
26,965,701
|
86,151
|
7,751,239
|
Bakari
Sellers
|
26,887,862
|
163,990
|
7,751,239
|
William F. Raines,
III
|
26,561,979
|
489,873
|
7,751,239
|
Peter J.
Ghiloni
|
26,689,314
|
362,538
|
7,751,239
|
Scott G.
Stephen
|
26,673,830
|
378,022
|
7,751,239
|
Sim
Farar
|
26,983,961
|
67,891
|
7,751,239
|
Proposal 2:
|
The
appointment of Cherry Bekaert LLP as our independent registered
public accounting firm was ratified, based upon the following final
tabulation of votes:
|
“For”
|
“Against”
|
“Abstain”
|
34,550,025
|
154,341
|
98,725
|
Proposal 3:
|
Our
2021 Equity Compensation Plan was approved, based upon the
following final tabulation of votes:
|
“For”
|
“Against”
|
“Abstain”
|
24,168,884
|
2,682,714
|
200,254
|
Proposal 3:
|
The compensation of our named executive officers was approved, on a
non-binding and advisory basis, based upon the following
final tabulation of votes:
|
“For”
|
“Against”
|
“Abstain”
|
26,266,273
|
392,271
|
393,308
|
Audit Committee:
|
William F. Raines, III, Chairman
|
|
Bakari Sellers
|
|
Scott G. Stephen
|
|
cbdMD,
Inc.
|
|
|
|
|
Date:
March 16, 2021
|
By:
|
/s/ T.
Ronan Kennedy
|
|
|
T.
Ronan Kennedy, Chief Financial Officer and Chief Operating
Officer
|
1 Year cbdMD Chart |
1 Month cbdMD Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions